We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Indian Diagnostic Company Transasia Bio-Medical Acquires Pliva Lachema Diagnostica

By LabMedica International staff writers
Posted on 20 Oct 2009
An Indian clinical diagnostics company, Transasia Bio-Medicals Ltd. More...
(Mumbai, India) has acquired Pliva Lachema Diagnostika (Brno, Czech Republic). The acquisition will bring advanced technology within reach for India's vast population.

The acquisition provides an opportunity for Transasia and ERBA to introduce newer products to the swiftly developing markets of Asia. Transasia and its 100% German subsidiary, ERBA Diagnostics Mannheim GmbH (Germany) have a team of experienced marketing and service professionals and a large distribution network. It markets products in countries, which include Italy, Germany, France, China, Turkey, Russia, and around the globe.

PLIVA Lachema Diagnostika develops, produces, and markets in vitro diagnostics (IVD) products for urine analysis, biochemistry, and microbiology. The company has an extensive marketing and distribution network in the countries of Central and Eastern Europe, which will complement the current market potential and product lines of Transasia and ERBA Mannheim

Lachema's customers in Central and Eastern Europe will have access to Transasia's large product range in clinical chemistry, immunoturbidimetry, and immunology. Transasia Bio-Medicals Ltd. and ERBA Diagnostics Mannheim intend to invest more than US$1 million in Lachema to increase its manufacturing capacities and add new quality, affordable, wide spectrum products in the near future.

Related Links:
Transasia Bio-Medicals Ltd.
Pliva Lachema Diagnostika



New
Gold Member
Thyroid-Stimulating Hormone Test
ULTRA-TSH
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Gold Member
Latex Test
SLE-Latex Test
New
STI Test
REALQUALITY RQ-SevenSTI
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The POC device rapidly predicts neonatal respiratory disease at birth in the NICU (Photo courtesy of SIME Diagnostics)

AI-Powered Lung Maturity Test Identifies Newborns at Higher Risk of Respiratory Distress

Each year, approximately 300,000 babies in the United States are born between 32 and 36 weeks' gestation, according to national health data. This group is at an elevated risk for respiratory distress,... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: A biomarker discovery pipeline has shown promise as a noninvasive method of diagnosing CRC (Photo courtesy of NCI Center for Cancer Research)

Machine Learning Tool Enables Noninvasive Diagnosis and Monitoring of Colorectal Cancer

Colorectal cancer (CRC) is the second leading cause of cancer-related deaths in the United States when considering both genders. Colonoscopy remains the gold standard for CRC diagnosis, but it is invasive,... Read more

Technology

view channel
Image: Scanning electron microscopy images showing 3D micro-printed Limacon-shaped whispering-gallery-mode microcavities with different amounts of deformation (Photo courtesy of A. Ping Zhang/PolyU)

Tiny Microlaser Sensors with Supercharged Biosensing Ability to Enable Early Disease Diagnosis

Optical whispering-gallery-mode microlaser sensors function by trapping light within tiny microcavities. When target molecules bind to the cavity, they induce subtle changes in the laser’s frequency, allowing... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.